The treatment of atopic dermatitis with systemic immunosuppressive agents.
Akhavan
Arash
A
Department of Dermatology, Mount Sinai School of Medicine, New York, New York 10029, USA.
Rudikoff
Donald
D
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D004804:Eosinophils / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007371:Interferon-gamma / Q000008:administration & dosage / Q000009:adverse effects; D007801:Langerhans Cells / Q000276:immunology; D008407:Mast Cells / Q000276:immunology; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D017410:Practice Guidelines as Topic; D012306:Risk; D018418:Th2 Cells / Q000276:immunology
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D007371:Interferon-gamma; D016572:Cyclosporine; D009173:Mycophenolic Acid